Table 3.
Correlation Between Serum HBsAg Titres and the Clinical Parameters in Various Phases of Persistent HBV-infections.
| All (n = 976) |
Immune tolerant phase (n = 123) |
Immune clearance phase (n = 192) |
Low-replicative phase (n = 476) |
HBeAg negative phase (n = 185) |
||||||
|---|---|---|---|---|---|---|---|---|---|---|
| HBsAg Vs |
r | P | r | P | r | P | r | P | r | P |
| Age | 0.136 | <0.001 | 0.016 | 0.852 | 0.017 | 0.070 | 0.041 | 0.364 | 0.040 | 0.579 |
| ALT | 0.229 | <0.001 | 0.016 | 0.854 | 0.101 | 0.161 | 0.037 | 0.415 | 0.049 | 0.499 |
| AST | 0.192 | <0.001 | 0.136 | 0.132 | 0.018 | 0.797 | 0.095 | 0.036 | 0.000 | 0.989 |
| Bilirubin | 0.013 | 0.664 | 0.045 | 0.614 | 0.069 | 0.339 | 0.139 | 0.002 | 0.028 | 0.698 |
HBsAg; hepatitis B surface antigen; ALT, alanine aminotransferase; AST, aspartate aminotransferase; HBeAg; hepatitis B early antigen; r, correlation coefficient; P, P-value.